Nonprescription Products for the Pregnant and Breast-Feeding Patient

W. Steven Pray, PhD, DPh

Disclosures

US Pharmacist. 2007;32(9):10-14. 

In This Article

Introduction

It is considered unethical for manufacturers to design prospective human trials to ascertain potential teratogenicity or to determine dangers to a baby when medications pass into breast milk.[1] Thus, pregnant and lactating females are often referred to as therapeutic orphans. Many of these patients choose nonprescription products on their own.[2] However, even when women do ask, pharmacists are hampered by the general lack of knowledge regarding the potential dangers of these products.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....